12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase 2a study is to evaluate the efficacy, safety and tolerability, of
multiple parallel doses of PF-00734200 following oral administration to adult human subjects
with T2DM who currently are on a stable dose of metformin.